Paweł Knapp

1.1k total citations
67 papers, 629 citations indexed

About

Paweł Knapp is a scholar working on Reproductive Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Paweł Knapp has authored 67 papers receiving a total of 629 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Reproductive Medicine, 20 papers in Molecular Biology and 14 papers in Oncology. Recurrent topics in Paweł Knapp's work include Ovarian cancer diagnosis and treatment (16 papers), Endometrial and Cervical Cancer Treatments (9 papers) and Endometriosis Research and Treatment (7 papers). Paweł Knapp is often cited by papers focused on Ovarian cancer diagnosis and treatment (16 papers), Endometrial and Cervical Cancer Treatments (9 papers) and Endometriosis Research and Treatment (7 papers). Paweł Knapp collaborates with scholars based in Poland, Germany and Czechia. Paweł Knapp's co-authors include Adrian Chabowski, Agnieszka Błachnio‐Zabielska, J Górski, Małgorzata Knapp, Lubomir Bodnar, Marcin Baranowski, Magdalena Świderska, Piotr Zabielski, Katarzyna Jarząbek and Robert Jach and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Paweł Knapp

64 papers receiving 615 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paweł Knapp Poland 14 242 163 130 128 109 67 629
Venkateshwari Ananthapur India 15 154 0.6× 92 0.6× 73 0.6× 72 0.6× 98 0.9× 73 547
Tomoko Uchiyama Japan 17 126 0.5× 111 0.7× 98 0.8× 119 0.9× 135 1.2× 68 684
Hiroe Ito Japan 16 182 0.8× 62 0.4× 150 1.2× 55 0.4× 136 1.2× 44 760
Renske de Jong Germany 8 174 0.7× 72 0.4× 65 0.5× 71 0.6× 33 0.3× 10 506
Bastian Czogalla Germany 15 237 1.0× 176 1.1× 107 0.8× 103 0.8× 77 0.7× 64 620
Petra Kleiblová Czechia 18 463 1.9× 323 2.0× 52 0.4× 199 1.6× 44 0.4× 47 1.0k
Zhihong Niu China 16 267 1.1× 98 0.6× 435 3.3× 74 0.6× 41 0.4× 62 924
Е. V. Tsyrlina Russia 12 391 1.6× 158 1.0× 72 0.6× 286 2.2× 35 0.3× 37 667

Countries citing papers authored by Paweł Knapp

Since Specialization
Citations

This map shows the geographic impact of Paweł Knapp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paweł Knapp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paweł Knapp more than expected).

Fields of papers citing papers by Paweł Knapp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paweł Knapp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paweł Knapp. The network helps show where Paweł Knapp may publish in the future.

Co-authorship network of co-authors of Paweł Knapp

This figure shows the co-authorship network connecting the top 25 collaborators of Paweł Knapp. A scholar is included among the top collaborators of Paweł Knapp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paweł Knapp. Paweł Knapp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chwiałkowska, Karolina, A. Zeller, Anna Skwarska, et al.. (2025). Repurposing of PI3K inhibitors for high-grade serous ovarian cancer: A novel competing endogenous network analysis-based approach. Computers in Biology and Medicine. 194. 110471–110471.
2.
3.
Kicman, Aleksandra, et al.. (2024). Diagnostic Utility of Selected Matrix Metalloproteinases (MMP-2, MMP-3, MMP-11, MMP-26), HE4, CA125 and ROMA Algorithm in Diagnosis of Ovarian Cancer. International Journal of Molecular Sciences. 25(11). 6265–6265. 2 indexed citations
4.
Rob, Lukáš, David Cibula, Paweł Knapp, et al.. (2022). Safety and efficacy of dendritic cell-based immunotherapy DCVAC/OvCa added to first-line chemotherapy (carboplatin plus paclitaxel) for epithelial ovarian cancer: a phase 2, open-label, multicenter, randomized trial. Journal for ImmunoTherapy of Cancer. 10(1). e003190–e003190. 31 indexed citations
5.
Knapp, Paweł, et al.. (2021). What do we know about perioperative hypersensitivity reactions and what can we do to improve perioperative safety?. Annals of Medicine. 53(1). 1772–1778. 3 indexed citations
6.
Concin, Nicole, François Planchamp, Nadeem R. Abu‐Rustum, et al.. (2021). European Society of Gynaecological Oncology quality indicators for the surgical treatment of endometrial carcinoma. International Journal of Gynecological Cancer. 31(12). ijgc–2021. 20 indexed citations
7.
Fotopoulou, Christina, François Planchamp, Luis Chiva, et al.. (2021). European Society of Gynaecological Oncology guidelines for the peri-operative management of advanced ovarian cancer patients undergoing debulking surgery. International Journal of Gynecological Cancer. 31(9). 1199–1206. 54 indexed citations
8.
Knapp, Paweł, et al.. (2021). Prognostic Significance of Survivin Expression in Patients with Ovarian Carcinoma: A Meta-Analysis. Journal of Clinical Medicine. 10(4). 879–879. 9 indexed citations
11.
Markowska, Anna, Robert Jach, Andrzej Marszałek, et al.. (2019). Significance of BRCA1 expression in breast and ovarian cancer patients with brain metastasis – A multicentre study. Advances in Medical Sciences. 64(2). 235–240. 7 indexed citations
12.
Knapp, Paweł, Paweł Blecharz, Lubomir Bodnar, et al.. (2019). Current management of cervical cancer in Poland—Analysis of the questionnaire trial for the years 2002-2014 in relation to ASCO 2016 recommendations. PLoS ONE. 14(1). e0209901–e0209901. 4 indexed citations
13.
Bodnar, Lubomir, Paweł Knapp, Jacek Jan Sznurkowski, et al.. (2019). Early initiation of chemotherapy after primary surgery as an adverse prognostic factor in patients with ovarian cancer. European Journal of Gynaecological Oncology. 40(2). 236–241.
14.
Basta, Antoni, Mariusz Bidziński, Andrzej Bieńkiewicz, et al.. (2015). Recommendation of the Polish Society of Oncological Gynaecology on the diagnosis and treatment of epithelial ovarian cancer. Oncology in Clinical Practice. 11(5). 233–243. 10 indexed citations
15.
Basta, Antoni, Mariusz Bidziński, Andrzej Bieńkiewicz, et al.. (2015). Rekomendacje Polskiego Towarzystwa Ginekologii Onkologicznej dotyczące diagnostyki i leczenia raka jajnika Wersja 2015.1. Via Medica Journals. 1(2). 83–93. 1 indexed citations
16.
Knapp, Paweł, et al.. (2013). Expression of Estrogen Receptors (α, β), Cyclooxygenase-2 and Aromatase in normal endometrium and endometrioid cancer of uterus. Advances in Medical Sciences. 58(1). 96–103. 19 indexed citations
17.
Knapp, Paweł, et al.. (2010). Czynność narządu przedsionkowego u kobiet w okresie menopauzy niestosujących hormonalnej terapii zastępczej (HTZ). Otolaryngologia Polska. 64(1). 10–14. 2 indexed citations
18.
Knapp, Paweł, et al.. (2005). Verrucous carcinoma of the cervix--diagnostic and therapeutic difficulties with regards to HPV status. Case report.. PubMed. 26(2). 227–30. 2 indexed citations
19.
Knapp, Paweł, et al.. (2005). How we can modify the risk of breast cancer. 4(6). 70–75. 2 indexed citations
20.
Knapp, Paweł, et al.. (2004). [The use of interactive medical data transfer to increase effectiveness of a mass screening program].. PubMed. 75(11). 896–903. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026